Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Nosology and classification of genetic skeletal disorders: 2010 revision.
|
Am J Med Genet A
|
2011
|
4.27
|
2
|
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
|
Nat Genet
|
2010
|
3.82
|
3
|
Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.
|
Nat Genet
|
2011
|
2.16
|
4
|
TRPM5 is a transient Ca2+-activated cation channel responding to rapid changes in [Ca2+]i.
|
Proc Natl Acad Sci U S A
|
2003
|
2.01
|
5
|
Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations.
|
Hum Mutat
|
2010
|
1.88
|
6
|
TBX15 mutations cause craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature in Cousin syndrome.
|
Am J Hum Genet
|
2008
|
1.68
|
7
|
Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.
|
Proc Natl Acad Sci U S A
|
2005
|
1.65
|
8
|
Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia.
|
Eur J Hum Genet
|
2006
|
1.63
|
9
|
Mutations in the TGFβ binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias.
|
Am J Hum Genet
|
2011
|
1.55
|
10
|
Of mice and models: improved animal models for biomedical research.
|
Physiol Genomics
|
2002
|
1.49
|
11
|
Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
|
Am J Hum Genet
|
2004
|
1.45
|
12
|
Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator.
|
Am J Hum Genet
|
2005
|
1.40
|
13
|
Mutations in WNT1 cause different forms of bone fragility.
|
Am J Hum Genet
|
2013
|
1.39
|
14
|
The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals.
|
Am J Med Genet C Semin Med Genet
|
2012
|
1.23
|
15
|
Spondylo-epiphyseal dysplasia, Maroteaux type (pseudo-Morquio syndrome type 2), and parastremmatic dysplasia are caused by TRPV4 mutations.
|
Am J Med Genet A
|
2010
|
1.20
|
16
|
Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia.
|
Hum Mol Genet
|
2005
|
1.19
|
17
|
Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: congenital dislocations and vertebral changes as principal diagnostic features.
|
Am J Med Genet A
|
2010
|
1.17
|
18
|
Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis.
|
Am J Hum Genet
|
2008
|
1.15
|
19
|
Interaction of TGFβ and BMP signaling pathways during chondrogenesis.
|
PLoS One
|
2011
|
1.13
|
20
|
Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution.
|
Hum Mutat
|
2011
|
1.13
|
21
|
Chondrodysplasia and abnormal joint development associated with mutations in IMPAD1, encoding the Golgi-resident nucleotide phosphatase, gPAPP.
|
Am J Hum Genet
|
2011
|
1.12
|
22
|
Filamin A mutation is one cause of FG syndrome.
|
Am J Med Genet A
|
2007
|
1.10
|
23
|
RMRP mutations in cartilage-hair hypoplasia.
|
Am J Med Genet A
|
2006
|
1.07
|
24
|
FAM111A mutations result in hypoparathyroidism and impaired skeletal development.
|
Am J Hum Genet
|
2013
|
1.06
|
25
|
Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor.
|
Nat Genet
|
2005
|
1.05
|
26
|
Spondyloperipheral dysplasia is caused by truncating mutations in the C-propeptide of COL2A1.
|
Am J Med Genet A
|
2004
|
1.03
|
27
|
Reversible anonymization of DICOM images using automatically generated policies.
|
Stud Health Technol Inform
|
2009
|
1.03
|
28
|
Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease.
|
J Clin Endocrinol Metab
|
2013
|
1.03
|
29
|
Localization of the cis-enhancer element for mouse type X collagen expression in hypertrophic chondrocytes in vivo.
|
J Bone Miner Res
|
2009
|
0.99
|
30
|
Osteopathia striata with cranial sclerosis owing to WTX gene defect.
|
J Bone Miner Res
|
2010
|
0.98
|
31
|
Mutations in the cyclin family member FAM58A cause an X-linked dominant disorder characterized by syndactyly, telecanthus and anogenital and renal malformations.
|
Nat Genet
|
2008
|
0.98
|
32
|
Mutations in MMP9 and MMP13 determine the mode of inheritance and the clinical spectrum of metaphyseal anadysplasia.
|
Am J Hum Genet
|
2009
|
0.98
|
33
|
Expression profile of Papss2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo.
|
Dev Dyn
|
2007
|
0.97
|
34
|
Behavioral phenotype in five individuals with de novo mutations within the GRIN2B gene.
|
Behav Brain Funct
|
2013
|
0.96
|
35
|
TRPV4-associated skeletal dysplasias.
|
Am J Med Genet C Semin Med Genet
|
2012
|
0.96
|
36
|
Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies.
|
Am J Med Genet A
|
2005
|
0.95
|
37
|
TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients.
|
Am J Med Genet A
|
2012
|
0.95
|
38
|
Brachy-syndactyly caused by loss of Sfrp2 function.
|
J Cell Physiol
|
2008
|
0.94
|
39
|
Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.
|
Cancer Res
|
2003
|
0.93
|
40
|
Refinement of the 12q14 microdeletion syndrome: primordial dwarfism and developmental delay with or without osteopoikilosis.
|
Eur J Hum Genet
|
2009
|
0.93
|
41
|
Viperin mRNA is a novel target for the human RNase MRP/RNase P endoribonuclease.
|
Cell Mol Life Sci
|
2010
|
0.88
|
42
|
Preselection of cases through expert clinical and radiological review significantly increases mutation detection rate in multiple epiphyseal dysplasia.
|
Eur J Hum Genet
|
2006
|
0.87
|
43
|
Lmx1b expression during joint and tendon formation: localization and evaluation of potential downstream targets.
|
Gene Expr Patterns
|
2004
|
0.85
|
44
|
Survival to adulthood and dominant inheritance of platyspondylic skeletal dysplasia, Torrance-Luton type.
|
Pediatr Radiol
|
2003
|
0.85
|
45
|
Expression profiling of human fetal growth plate cartilage by EST sequencing.
|
Matrix Biol
|
2005
|
0.84
|
46
|
Grebe dysplasia and the spectrum of CDMP1 mutations.
|
Pediatr Pathol Mol Med
|
2003
|
0.84
|
47
|
Identification of a Ninein (NIN) mutation in a family with spondyloepimetaphyseal dysplasia with joint laxity (leptodactylic type)-like phenotype.
|
Matrix Biol
|
2013
|
0.81
|
48
|
Fetal akinesia in metatropic dysplasia: The combined phenotype of chondrodysplasia and neuropathy?
|
Am J Med Genet A
|
2011
|
0.81
|
49
|
SPOC1, a novel PHD-finger protein: association with residual disease and survival in ovarian cancer.
|
Int J Cancer
|
2005
|
0.80
|
50
|
Clinical Utility Gene Card for: campomelic dysplasia.
|
Eur J Hum Genet
|
2012
|
0.78
|
51
|
Dephosphorylation of p-ERK1/2 in relation to tumor remission after HER-2 and Raf1 blocking therapy in a conditional mouse tumor model.
|
Mol Carcinog
|
2006
|
0.77
|
52
|
Clinical and radiographic delineation of odontochondrodysplasia.
|
Am J Med Genet A
|
2008
|
0.77
|
53
|
C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
|
J Clin Endocrinol Metab
|
2014
|
0.76
|
54
|
In vitro cultured islet-derived progenitor cells of human origin express human albumin in severe combined immunodeficiency mouse liver in vivo.
|
Stem Cells
|
2004
|
0.75
|
55
|
Al-Awadi-Raas-Rothschild (limb/pelvis/uterus-hypoplasia/aplasia) syndrome and WNT7A mutations: genetic homogeneity and nosological delineation.
|
Am J Med Genet A
|
2010
|
0.75
|